Issued Patents All Time
Showing 1–23 of 23 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12227490 | Cereblon binding compounds, compositions thereof, and methods of treatment therewith | Matthew D. Alexander, Matthew D. Correa, Deepak Dalvie, Virginia Heather Sharron Grant, Joshua Hansen +8 more | 2025-02-18 |
| 12103920 | Cereblon binding compounds, compositions thereof, and methods of treatment therewith | Matthew D. Alexander, Matthew D. Correa, Deepak Dalvie, Virginia Heather Sharron Grant, Joshua Hansen +8 more | 2024-10-01 |
| 11945804 | Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith | Matthew D. Alexander, Soraya Carrancio, Matthew D. Correa, Virginia Heather Sharron Grant, Joshua Hansen +5 more | 2024-04-02 |
| 11739075 | Cereblon binding compounds, compositions thereof, and methods of treatment therewith | Matthew D. Alexander, Matthew D. Correa, Deepak Dalvie, Virginia Heather Sharron Grant, Joshua Hansen +8 more | 2023-08-29 |
| 11634407 | Cereblon binding compounds, compositions thereof, and methods of treatment therewith | Matthew D. Alexander, Matthew D. Correa, Deepak Dalvie, Virginia Heather Sharron Grant, Joshua Hansen +8 more | 2023-04-25 |
| 11560371 | Cereblon binding compounds, compositions thereof, and methods of treatment therewith | Matthew D. Alexander, Matthew D. Correa, Deepak Dalvie, Virginia Heather Sharron Grant, Joshua Hansen +8 more | 2023-01-24 |
| 11358952 | Substituted 4-aminoisoindoline-1,3-dione compounds, compositions thereof, and methods of treatment therewith | Matthew D. Alexander, Soraya Carranclo, Matthew D. Correa, Virginia Heather Sharron Grant, Joshua Hansen +5 more | 2022-06-14 |
| 11292796 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Jan Elsner, Branden Lee, Deborah Mortensen, Garrick Packard, Patrick Papa +7 more | 2022-04-05 |
| 10683298 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Jan Elsner, Branden Lee, Deborah Mortensen, Garrick Packard, Patrick Papa +7 more | 2020-06-16 |
| 10167290 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Jan Elsner, Branden Lee, Deborah Mortensen, Garrick Packard, Patrick Papa +7 more | 2019-01-01 |
| 9795607 | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang +11 more | 2017-10-24 |
| 9771371 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Jan Elsner, Branden Lee, Deborah Mortensen, Garrick Packard, Patrick Papa +7 more | 2017-09-26 |
| 9428509 | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang +11 more | 2016-08-30 |
| 9346812 | Substituted pyrrolopyrimidine compounds, compositions thereof, and methods of treatment therewith | Andrew Antony Calabrese, Brandon Jeffy, Dale Robinson, Dan Zhu, Dehua Huang +11 more | 2016-05-24 |
| 9193692 | Halogen substituted pyrazines as intermediates of mTOR kinase inhibitors | Sophie Perrin-Ninkovic, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +6 more | 2015-11-24 |
| 9079900 | Methods of synthesis and purification of heteroaryl compounds | John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee, Garrick Packard +13 more | 2015-07-14 |
| 8907087 | Substituted pyrazino[2,3-b]pyrazines as mTOR kinase inhibitors | Sophie Perrin-Ninkovic, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +6 more | 2014-12-09 |
| 8569494 | Methods of synthesis and purification of heteroaryl compounds | John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee, Garrick Packard +13 more | 2013-10-29 |
| 8507492 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/AKT pathway | Sophie Perrin-Ninkovic, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +12 more | 2013-08-13 |
| 8492381 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitor for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway | Sophie Perrin-Ninkovic, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +12 more | 2013-07-23 |
| 8372976 | Methods of treatment comprising the administration of heteroaryl compounds | Deborah Mortensen, Maria Mercedes Delgado Mederos, John Sapienza, Ronald Albers, Branden Lee +9 more | 2013-02-12 |
| 8110578 | Pyrazino[2,3-b]pyrazine mTOR kinase inhibitors for oncology indications and diseases associated with the mTOR/PI3K/Akt pathway | Sophie Perrin-Ninkovic, John Sapienza, Graziella I. Shevlin, Patrick Papa, Branden Lee +12 more | 2012-02-07 |
| 7981893 | Heteroaryl compounds, compositions thereof, and methods of treatment therewith | Deborah Mortensen, Maria Mercedes Delgado Mederos, John Sapienza, Ronald Albers, Branden Lee +9 more | 2011-07-19 |